ADICET BIO INC (ACET)       8.49  -0.08 (-0.93%)

8.49  -0.08 (-0.93%)

US0070021086 - Common Stock - After market: 8.58 +0.09 (+1.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
17.9M9.73M
-45.64%
36.105M
271.07%
EBITDA
-85.33M
-115.32%
-37.96M
55.51%
-58.695M
-54.62%
-66.3M
-12.96%
N/AN/AN/AN/AN/AN/A
EBIT
-85.46M
-115.21%
-39.19M
54.14%
-60.233M
-53.69%
-65.542M
-8.81%
Operating Margin
N/A-218.94%-619.04%-181.53%
EPS
-16.52
-62.76%
-5.68
65.62%
-2.07
63.56%
-1.53
26.03%
N/A

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS-0.54
-22.17%
-0.28
39.45%
Revenue339.997K
-90.08%
11.787M
115.56%
EBITDA-24.48M-24.48MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT-22.322M
-62.81%
-12.061M
15.90%
N/AN/AN/AN/A

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 -0.53 -0.54 0.011.40% Q2 2022 -0.56 -0.46 -0.10-20.66% Q1 2022 0.10 -0.19 0.29153.87% Q4 2021 -0.47 -0.43 -0.04-9.39% Q3 2021 -0.44 -0.45 0.011.96% Q2 2021 -0.34 -0.54 0.2037.11% Q1 2021 -0.82 -0.50 -0.32-64.63% Q4 2020 -0.46 -0.90 0.4448.75%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 339.997K -339.997K-100.00% Q2 2022 994.5K -994.5K-100.00% Q1 2022 24.99M 13.964M 11.026M78.96% Q4 2021 5.468M 4.246M 1.222M28.78% Q3 2021 3.429M 2.739M 690K25.19% Q2 2021 4.814M 1.87M 2.944M157.43% Q1 2021 -3.98M 680.003K -4.66M-685.29% Q4 2020 5.41M 5.41M∞%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPS0% 6.38% 0% -16.82%
Revenue0% 1.96% 0% 1.07%